These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 9337446)

  • 1. The AHCPR clinical practice guideline for heart failure revisited.
    Adams KF; Ellis ML; Williamson KM; Patterson JH
    Ann Pharmacother; 1997 Oct; 31(10):1197-204. PubMed ID: 9337446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Left ventricular diastolic heart failure with normal left ventricular systolic function in older persons.
    Aronow WS
    J Lab Clin Med; 2001 May; 137(5):316-23. PubMed ID: 11329528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of heart failure. I. Pharmacologic treatment.
    Baker DW; Konstam MA; Bottorff M; Pitt B
    JAMA; 1994 Nov; 272(17):1361-6. PubMed ID: 7933398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Congestive heart failure: what should be the initial therapy and why?
    Chatterjee K
    Am J Cardiovasc Drugs; 2002; 2(1):1-6. PubMed ID: 14727993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current medical therapy for advanced heart failure.
    Gheorghiade M; Cody RJ; Francis GS; McKenna WJ; Young JB; Bonow RO
    Heart Lung; 2000; 29(1):16-32. PubMed ID: 10636954
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical treatment regimens for chronic heart failure: a review.
    Gould PA; Kaye DM
    Expert Opin Pharmacother; 2002 Nov; 3(11):1569-76. PubMed ID: 12437491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacologic therapy for patients with chronic heart failure and reduced systolic function: review of trials and practical considerations.
    Klein L; O'Connor CM; Gattis WA; Zampino M; de Luca L; Vitarelli A; Fedele F; Gheorghiade M
    Am J Cardiol; 2003 May; 91(9A):18F-40F. PubMed ID: 12729848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical management of mild-to-moderate heart failure before the advent of beta blockers.
    Abraham WT; Wagoner LE
    Am J Med; 2001 May; 110 Suppl 7A():47S-62S. PubMed ID: 11334776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An evidence-based review of recent advances in therapy for heart failure with reduced ejection fraction (HFrEF).
    Raj L; Adhyaru B
    Postgrad Med J; 2016 Dec; 92(1094):726-734. PubMed ID: 27708003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Trends in pharmacological treatment of congestive heart failure].
    Halawa B
    Pol Merkur Lekarski; 1999 Mar; 6(33):152-6. PubMed ID: 10365602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological treatment of chronic heart failure.
    Adorisio R; De Luca L; Rossi J; Gheorghiade M
    Heart Fail Rev; 2006 Jun; 11(2):109-23. PubMed ID: 16937030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacotherapy for heart failure with left ventricular dysfunction: beyond angiotensin-converting enzyme inhibitors and beta-blockers.
    Norgard NB; Stark JE
    Pharmacotherapy; 2008 Jul; 28(7):920-31. PubMed ID: 18576907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacotherapy implications of revised chronic heart failure guidelines.
    Crouch MA
    Consult Pharm; 2006 Jul; 21(7):576-82. PubMed ID: 16934010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The AHCPR guidelines on heart failure: comparison of a family medicine and an internal medicine practice with the guidelines and an educational intervention to modify behavior.
    Chodoff P; Bischof RO; Nash DB; Laine C
    Clin Perform Qual Health Care; 1996; 4(4):179-85. PubMed ID: 10162148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal trends in pharmacotherapy for congestive heart failure at an academic medical center: 1990-1995.
    Rich MW; Brooks K; Luther P
    Am Heart J; 1998 Mar; 135(3):367-72. PubMed ID: 9506320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of increased dose of diuretics on symptoms, weight, 6-minute walk distance, and echocardiographic measurements of left ventricular systolic and diastolic function in 51 patients with symptomatic heart failure caused by reduced left ventricular ejection fraction treated with beta blockers and angiotensin-converting enzyme inhibitors or angiotensin receptor blockers.
    Kumar A; Aronow WS; Vadnerkar A; Sivan K; Mittal S
    Am J Ther; 2009; 16(1):5-7. PubMed ID: 19142162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guideline for the management of heart failure caused by systolic dysfunction: part II. Treatment.
    Chavey WE; Blaum CS; Bleske BE; Harrison RV; Kesterson S; Nicklas JM;
    Am Fam Physician; 2001 Sep; 64(6):1045-54. PubMed ID: 11578026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacologic management of heart failure caused by systolic dysfunction.
    Chavey WE; Bleske BE; Van Harrison R; Hogikyan RV; Kesterson SK; Nicklas JM
    Am Fam Physician; 2008 Apr; 77(7):957-64. PubMed ID: 18441861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Contemporary approaches to diagnosis and management of chronic heart failure (summary of the American College of Cardiology/American Heart Association Guidelines)].
    Sidorenko BA; Preobrazhensky DV; Batyraliev TA; Marenitch AV; Romanova NE
    Kardiologiia; 2002; 42(6):65-78. PubMed ID: 12494135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Halting the progression of heart failure: finding the optimal combination therapy.
    Basile JN
    Cleve Clin J Med; 2002 Feb; 69(2):104-5, 109-10, 112. PubMed ID: 11990640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.